This company seems to have been delisted
Reason: Filed for bankruptcy
Last recorded trade on: June 22, 2023
Source: https://www.bloomberg.com/news/articles/2023-05-03/generic-drugmaker-lannett-files-for-chapter-11-bankruptcy
Reason: Filed for bankruptcy
Last recorded trade on: June 22, 2023
Source: https://www.bloomberg.com/news/articles/2023-05-03/generic-drugmaker-lannett-files-for-chapter-11-bankruptcy
Lannett Company
LCI
A$1.05
Share price
0.00%
Change (1 day)
-69.82%
Change (1 year)
Categories
Earnings for Lannett Company (LCI)
Earnings in 2023 (TTM): -A$0.3 Billion
According to Lannett Company's latest financial reports the company's current earnings are A$0.31 Billion. In 2022 the company made an earning of -A$0.21 Billion a decrease over its 2021 earnings that were of -A$0.17 Billion. The earnings displayed on this page is the company's Pretax Income.
Earnings history for Lannett Company from 2000 to 2023
Annual earnings
| Year | Earnings | Change |
|---|---|---|
2023 (TTM)  | -A$0.3 Billion | 42.71% |
| 2022 | -A$0.21 Billion | 23.09% |
| 2021 | -A$0.17 Billion | -51.41% |
| 2020 | -A$0.35 Billion | -424.46% |
| 2019 | A$0.10 B | -126.23% |
| 2018 | -A$0.41 Billion | -255.9% |
| 2017 | A$0.25 B | 170.58% |
| 2016 | A$95.63 M | -66.69% |
| 2015 | A$0.28 B | -4.54% |
| 2014 | A$0.30 B | 619.53% |
| 2013 | A$41.8 M | 80.15% |
| 2012 | A$23.2 M | -908.06% |
| 2011 | -A$2.88 Million | -118.48% |
| 2010 | A$15.54 M | -17.12% |
| 2009 | A$18.75 M | 453.37% |
| 2008 | A$3.38 M | -119.89% |
| 2007 | -A$17.05 Million | -239.11% |
| 2006 | A$12.24 M | -115.19% |
| 2005 | -A$80.63 Million | -532.64% |
| 2004 | A$18.63 M | -47.76% |
| 2003 | A$35.67 M | 41.23% |
| 2002 | A$25.25 M | 165.35% |
| 2001 | A$9.51 M | 5002.96% |
| 2000 | A$0.18 M |
Earnings for similar companies or competitors
| Company | Earnings | Earnings differencediff. | Country |
|---|---|---|---|
 Pfizer PFE | A$15.86 B | -5,314.59% | 🇺🇸 USA |
 Johnson & Johnson JNJ | A$42.06 B | -13,920.86% | 🇺🇸 USA |
 Abbott Laboratories ABT | A$11.28 B | -3,808.86% | 🇺🇸 USA |
 Novartis NVS | A$22.89 B | -7,622.60% | 🇨🇭 Switzerland |
 GlaxoSmithKline GSK | A$8.29 B | -2,826.46% | 🇬🇧 UK |